You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GALT Exercise Disclosure
Jamil Khurram · SEC Form 4 · Filed Jun 25, 2026
Exercise
Calculated transaction value
$9.3K
Jamil Khurram Chief Medical Officer
GALT
Transaction date
Jun 23, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 2 days later
GALT daily price context
Close on/before transaction
$3.12
Jun 23, 2026
First close after public filing
$4.99
Jun 26, 2026
30-day return after filing
-32.26%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,557 shares @ $1.23
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001133416-26-000057
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$33.02K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galectin Therapeutics Inc GALT Current | Exercise | Jun 23, 2026 | $9.3K |
| Galectin Therapeutics Inc GALT | Sale | Jun 23, 2026 | $23.73K |
| Galectin Therapeutics Inc GALT | Exercise | Jun 23, 2026 | $0 |